Relapsing generalized bullous fixed drug eruption: A severe and avoidable cutaneous drug reaction. Three case reports.
Braesch C, Weill A, Gaudin O, Lebrun-Vignes B, Bernigaud C, Hua C, Ortonne N, Nakad L, Chambrin V, Chosidow O, Wolkenstein P, Thomas L, Assier H, Ingen-Housz-Oro S.
Braesch C, et al.
Therapie. 2022 May-Jun;77(3):378-381. doi: 10.1016/j.therap.2021.04.004. Epub 2021 Apr 16.
Therapie. 2022.
PMID: 33962797
No abstract available.